Better influenza vaccines: an industry perspective
Open Access
- 14 February 2020
- journal article
- review article
- Published by Springer Science and Business Media LLC in Journal of Biomedical Science
- Vol. 27 (1), 1-11
- https://doi.org/10.1186/s12929-020-0626-6
Abstract
Vaccination is the most effective measure at preventing influenza virus infections. However, current seasonal influenza vaccines are only protective against closely matched circulating strains. Even with extensive monitoring and annual reformulation our efforts remain one step behind the rapidly evolving virus, often resulting in mismatches and low vaccine effectiveness. Fortunately, many next-generation influenza vaccines are currently in development, utilizing an array of innovative techniques to shorten production time and increase the breadth of protection. This review summarizes the production methods of current vaccines, recent advances that have been made in influenza vaccine research, and highlights potential challenges that are yet to be overcome. Special emphasis is put on the potential role of glycoengineering in influenza vaccine development, and the advantages of removing the glycan shield on influenza surface antigens to increase vaccine immunogenicity. The potential for future development of these novel influenza vaccine candidates is discussed from an industry perspective.Keywords
Funding Information
- Academic Sinica Genomics Research Center Summit Project (AS-SUMMIT-108)
This publication has 98 references indexed in Scilit:
- Deliberate reduction of hemagglutinin and neuraminidase expression of influenza virus leads to an ultraprotective live vaccine in miceProceedings of the National Academy of Sciences of the United States of America, 2013
- Effect of Priming with H1N1 Influenza Viruses of Variable Antigenic Distances on Challenge with 2009 Pandemic H1N1 VirusJournal of Virology, 2012
- Live and Inactivated Influenza Vaccines Induce Similar Humoral Responses, but Only Live Vaccines Induce Diverse T-Cell Responses in Young ChildrenThe Journal of Infectious Diseases, 2011
- A fast track influenza virus vaccine produced in insect cellsJournal of Invertebrate Pathology, 2011
- Live attenuated influenza virus vaccines by computer-aided rational designNature Biotechnology, 2010
- Cross-Neutralization of 1918 and 2009 Influenza Viruses: Role of Glycans in Viral Evolution and Vaccine DesignScience Translational Medicine, 2010
- Glycans on influenza hemagglutinin affect receptor binding and immune responseProceedings of the National Academy of Sciences of the United States of America, 2009
- Antigenic and Genetic Characteristics of Swine-Origin 2009 A(H1N1) Influenza Viruses Circulating in HumansScience, 2009
- Prevention of Antigenically Drifted Influenza by Inactivated and Live Attenuated VaccinesThe New England Journal of Medicine, 2006
- Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983Virology, 1990